Skip to content

Search for drugs effective against COVID-19 includes Alabama institutions

Apr 29, 2020


The work centers around ReFRAME, a vast collection of drugs already known to be safe for treating other diseases. Researchers at Calibr, the drug development division of Scripps Research, are teaming up with scientists from the United States, Europe and Asia to screen individual drugs or combinations that may be effective in treating people exposed to COVID-19.

Dr. Rich Whitley, distinguished professor of pediatrics, will lead the UAB effort.Alabama NewsCenter



Learn more about the
Life Sciences Industry in Alabama

Subscribe To Our Newsletter

Something went wrong. Please check your entries and try again.